These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21397488)

  • 41. Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study.
    Kepka L; Tatro D; Moran JM; Quint LE; Hayman JA; Ten Haken RK; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1397-403. PubMed ID: 19046824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of simple IMRT delivery techniques for non-small cell lung cancer patients with respiratory motion using 4DCT.
    Reitz B; Parda DS; Colonias A; Lee V; Miften M
    Med Dosim; 2009; 34(2):158-69. PubMed ID: 19410146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
    Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
    Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer.
    Martin KL; Gomez J; Nazareth DP; Warren GW; Singh AK
    Med Dosim; 2012; 37(2):182-5. PubMed ID: 21978531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lung cancer and elective nodal irradiation: A solved issue?].
    Laurans M; Botticella A; Moukasse Y; Lévy A; Le Péchoux C
    Cancer Radiother; 2019 Oct; 23(6-7):701-707. PubMed ID: 31501024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
    Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
    Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
    J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphatic drainage, CTV and molecular imaging in non-small cell lung cancer.
    Trodella L; Ciresa M; D'Angelillo R; Ramella S
    Rays; 2003; 28(3):299-302. PubMed ID: 15018317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
    Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
    Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
    Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.
    Kepka L; Maciejewski B; Withers RH
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1391-6. PubMed ID: 19306748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation.
    Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
    Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
    Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.